MedTrace Logo

The Role of Clinical Pharmacist in Management of DDIs in CHF Patients

NCT01855165 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-05-16

No results posted yet for this study

Summary

Drug-drug interactions (DDIs) are common in patients with chronic heart failure (CHF) and their incidence increases with the number of drugs that the patients are prescribed for treatment of their condition. Data bases often detect DDIs that are of high clinical relevance. The investigators have performed this study in order to detect clinically significant DDIs and to diminish their occurrence by sending notification about DDIs to attending physician.

Conditions

Interventions

BEHAVIORAL

Advice on DDIs

Sponsors & Collaborators

  • The University Clinic of Pulmonary and Allergic Diseases Golnik

    lead OTHER

Principal Investigators

  • Mitja Lainscak, PhD · University Clinic Golnik

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01855165 on ClinicalTrials.gov